BRIAN GRAHAM: Open Payments
NPI 1841636404 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,057 in 120 payments from 16 companies in 2025. Trend: 2023 $2,733 · 2024 $2,498 · 2025 $2,057
Food & beverage: $2,057
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 23 | $423 |
| ABBVIE INC. | 23 | $332 |
| Tris Pharma Inc | 17 | $283 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $248 |
| Corium, LLC | 10 | $243 |
| Neos Therapeutics, LP | 18 | $191 |
| Teva Pharmaceuticals USA, Inc. | 3 | $69 |
| Bausch Health US, LLC | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Noven Therapeutics, LLC | 2 | $34 |
Products named: LYBALVI, VRAYLAR, CAPLYTA, Azstarys, Adzenys XR-ODT, Dyanavel XR, Onyda XR, APLENZIN.
Industry payments across TX — which companies pay providers there.
